An extraction-free one-pot immunomagnetic-RPA-CRISPR/Cas13a platform for ultrasensitive detection of exosomal PD-L1
Analytica Chimica Acta · 2026-12 · 1426 · 346335
DOI: 10.1016/j.aca.2026.346335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026-12. Verfasst von Hansen Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, PR China; Key Laboratory of Antibody Engineeri…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Exosomes, CRISPR-Cas Systems, Nucleic Acid Amplification Techniques. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Programmed death-ligand 1 (PD-L1) expressed on the surface of exosomes (exo) is a promising liquid biopsy biomarker for monitoring response to immunotherapy in hepatocellular carcinoma (HCC). However, existing detection methods are limited by insufficient sensitivity and complicated operation. To address this, we developed an extraction-free immunomagnetic recombinase polymerase amplification (RPA)-based one-pot high-sensitivity CRISPR/Cas13a platform (iMRO-HCRISPR) employing DNA-conjugated antibodies. Exosomes in blood were enriched with anti-CD63/CD81/CD9 antibody-conjugated magnetic beads and recognized by PD-L1-specific DNA-antibody probes; the probe DNA then underwent RPA amplification, in vitro transcription (IVT), and Cas13a trans-cleavage, achieving multi-level signal amplification with fluorescent readout. Toehold-mediated DNA affinity pull-down effectively reduced the detection background. The platform achieved a limit of detection (LOD) as low as 101 particles/mL (positive detection at the single-particle level), a limit of quantification (LOQ) of 103 particles/mL, and a quantitative range of 103-1011 particles/mL, with the entire process completed in a single closed tube without exosome isolation. Clinical validation demonstrated that the platform effectively distinguished HCC patients from healthy controls (P < 0.0001), with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.964. This study provides robust technical support for the ultrasensitive detection of exosomal PD-L1 in HCC and for dynamic monitoring of immunotherapy response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, PR China; Key Laboratory of Antibody Engineering of Guangdong Higher Education Institutes, School of Laboratory Medi…
- Medical Laboratory Center, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong, PR China.
- Institute of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guangdong Medical University, Zhanjiang, Guangdong, 524023, PR China.
- Laboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, PR China.
- Key Laboratory of Antibody Engineering of Guangdong Higher Education Institutes, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, PR China. Electronic address: liutc@sm…
- Laboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, PR China. Electronic address: zengt@smu.edu.cn.
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Shi, H., Chen, J., Lin, X., Zhang, Y., Wu, H., Zeng, B., Zhang, P., Luo, Q., Liu, T., & Zeng, T. (2026). An extraction-free one-pot immunomagnetic-RPA-CRISPR/Cas13a platform for ultrasensitive detection of exosomal PD-L1. Analytica Chimica Acta, 1426, 346335. https://doi.org/10.1016/j.aca.2026.346335
Vancouver
Shi H, Chen J, Lin X, Zhang Y, Wu H, Zeng B, et al. An extraction-free one-pot immunomagnetic-RPA-CRISPR/Cas13a platform for ultrasensitive detection of exosomal PD-L1. Analytica Chimica Acta. 2026;1426:346335. doi:10.1016/j.aca.2026.346335
BibTeX
@article{Shi2026,
author = {Shi, Hansen and Chen, Jiayi and Lin, Xiaocong and Zhang, Yaning and Wu, Haiqi and Zeng, Biyun and Zhang, Peijun and Luo, Qianying and Liu, Tiancai and Zeng, Tao},
title = {An extraction-free one-pot immunomagnetic-RPA-CRISPR/Cas13a platform for ultrasensitive detection of exosomal PD-L1},
journal = {Analytica Chimica Acta},
year = {2026},
volume = {1426},
pages = {346335},
doi = {10.1016/j.aca.2026.346335}
}
EUVIMED